Science Creates is a Bristol-based deep tech ecosystem, supported and backed by successful entrepreneurs that help scientists and engineers accelerate their ideas and build disruptive businesses from scientific discoveries.
In partnership with the University of Bristol, Science Creates aims to establish Bristol as a global centre for deep tech by combining specialist incubator facilities (Unit DX and DY), a network of strategic partners and a dedicated venture capital fund.
In partnership with the University of Bristol and Research England, our two central Bristol incubators, Unit DX and Unit DY, offer 45,000 sq. ft of laboratory, office and event space for deep tech start-ups.
We designed our Unit DX and Unit DY Incubators for scientists and engineers using input from our own experiences working in laboratories. Our specialist in-house team designed, developed and run the spaces and coordinate our network to provide mentoring, expertise and the resources needed for deep tech innovation and business development. Our incubators take no equity.
Science Creates Ventures is a Bristol-based venture capital firm. Science Creates Ventures EIS Fund 1 offers investment into early-stage deep tech companies. Our focus is on technologies that have the potential to improve healthcare, quality of life, and the environment around us. Science Creates Ventures is supported and backed by successful entrepreneurs behind multiple tech and deep tech exits in the South-West
The Science Creates Network is made up of our member deep tech companies and our partnerships with local academic institutions, entrepreneurs, investors and strategic service providers. As sector specialists, we know that deep tech businesses need the right equipment, mentors and advisors with specific, relevant experience
“Science Creates brings a new component to the [Bristol] cluster: Science. No longer do science start-ups have to look elsewhere.
“The deep science IP of the universities and their graduates can take root here in Bristol. And as the activities grow they will combine with existing strengths in technology and arts and enable new areas of innovation and entrepreneurship.”
CytoSeek’s mission is to use cell membrane augmentation technology to unlock the potential of next generation of advanced therapies. Their novel cell membrane augmentation technology enables them to add new functionalities to cell therapies including tissue-specific targeting and enhanced cell survivability. Cytoseek are a spinout company from the University of Bristol.
Imophoron is developing a novel vaccine platform for use on
emerging infectious diseases. The platform is based on a single
component of the human Adenovirus that spontaneously forms a
superparticle, the ADDomer.
QLM is developing compact, high-sensitivity, low-power Tuneable Diode Lidar (TDLidar) gas detection and imaging systems based on infrared single-photon detection to meet the needs of natural gas producers, distributors and service providers for fast, accurate and low-cost gas leak identification.
Folium Science researches and develops Biome Modulators for the agriculture and food sector. Our unique CRISPR technology harnesses bacteria’s natural defense to bio-actively maintain bacterial populations which can support animal nutrition, plant health and soil condition. This organic, non GMO, non-antibiotic solution has the potential to change the way we manage our food value chain in the future.
Carbometrics is a specialist chemistry company based in Bristol, UK. Their core competency is the design, synthesis and derivatisation of highly selective and robust carbohydrate-binding molecules.
Facilitating the next generation of supercapacitors, batteries, thermal materials, and air purification systems by enhancing their constituent technologies with graphene.